Key Takeaways
- • US-based private equity and venture capital firms invested $72.14 billion in Europe during 2025, representing a 3.16% year-over-year increase and the highest level in four years, signaling robust recovery in European deal activity.
- • European private equity transaction values reached a five-year high, driven substantially by waste management and environmental sector deals, reflecting institutional investor appetite for sustainable infrastructure and operational improvements.
- • Deal volume across Europe exceeded 2024 levels with improved sentiment moving into Q4 2025, as global sponsors demonstrated renewed confidence in European buyout opportunities despite regional economic headwinds.
- • Healthcare emerged as a secondary growth driver with $13.33 billion in transaction value, complementing the waste sector's dominant contribution to the record transaction totals.
- • The surge in cross-border activity underscores a strategic pivot toward operational value creation and ESG-aligned investments, particularly in resilient Southern European markets offering attractive valuations.
Summary
US-based private equity and venture capital firms led this expansion, channeling $72.14 billion into European investments in 2025, up 3.16% year-over-year and marking the strongest performance in four years. This capital influx demonstrates renewed confidence in European markets after a prolonged period of subdued dealmaking activity. The acceleration in US sponsor participation reflects broader industry recognition that European valuations remain attractive relative to North American equivalents, coupled with operational improvement opportunities in fragmented, family-owned businesses.
Deal volume across the continent moved into positive territory, with European buyout activity on pace to exceed 2024 levels by Q3 and sentiment remaining constructive through year-end. The waste and environmental services sector dominated transaction value, while healthcare ranked as the secondary growth engine with $13.33 billion in transaction value. This sectoral concentration indicates that sponsors are targeting both inflation-protected, mission-critical infrastructure alongside healthcare providers offering operational leverage and consolidation opportunities.
The geographic breadth of activity widened notably, with Southern European markets experiencing a renaissance in private equity interest. Investors cited resilient regional economies, compressed valuations relative to Northern Europe, and cross-border consolidation potential as primary investment drivers. This geographic diversification reduces sponsor reliance on traditional West European markets and positions the region to capture mid-market opportunities in less saturated segments. The combination of improved deal flow, global sponsor participation, and sector-specific tailwinds positions European private equity for sustained momentum through 2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.